InvestorsHub Logo
Followers 15
Posts 571
Boards Moderated 1
Alias Born 08/04/2011

Re: None

Friday, 08/25/2017 6:47:52 PM

Friday, August 25, 2017 6:47:52 PM

Post# of 1140
CHO Platforms Unsustainable.

BioPharma Reporter.

CHO platforms unsustainable for biopharma's future, says Dyadic
By Dan Stanton+, 25-Aug-2017

Industry is feeling the low yield and high cost limitations of the CHO cell line and must look to alternatives to make next-generation biological products, says fungal-based protein expression firm Dyadic International.

http://www.biopharma-reporter.com/Upstream-Processing/CHO-cell-lines-unsustainable-for-biopharma-s-future-says-Dyadic
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News